DVAX — Dynavax Technologies Share News
0.000.00%
Last trade - 00:00- $1.76bn
- $1.38bn
- $277.25m
Brief: Deep Track Biotechnology Master Fund, Ltd. Reports 9.56% Stake In Dynavax Technologies Corp As Of Sept 16- SEC Filing
Brief: Lantheus Appoints Julie Eastland As New Board Member
Dynavax Technologies Corp reports results for the quarter ended in June - Earnings Summary
Brief: Dynavax Technologies Q2 EPS USD 0.09
Brief: Dynavax Technologies Re-Appointed Kelly MacDonald As CFO
Brief: Dynavax Initiates Phase 1/2 Study Of Novel Shingles Vaccine Program
U.S. STOCKS ON THE MOVE-Robinhood Markets, Alibaba Group, Intuitive Machines
Dynavax falls as FDA declines expanded use of hepatitis B vaccine in dialysis patients
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine (updated)
Brief: Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B Regimen for Adults on Hemodialysis in the U.S.
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
Brief: Dynavax Technologies Q1 EPS USD -0.07
Dynavax Technologies Corp expected to post a loss of 2 cents a share - Earnings Preview
Brief: Dynavax Technologies Appointed Ryan Spencer To Serve In A Temporary Capacity As Interim CFO
Dynavax Technologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: Dynavax Reports Fourth Quarter And Full Year 2023 Financial Results And Provides Full Year 2024 Financial Guidance
Brief: Dynavax Technologies Q4 Net Income USD 219 Thousand
Dynavax Technologies Corp reports results for the quarter ended in September - Earnings Summary
Brief: Dynavax Technologies Q3 Net Income USD 14.293 Million